Mevastatin hydroxy acid sodium salt
CAS : 99782-89-5
Ref. 3D-FM25992
| 10mg | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté | ||
| 250mg | Arrêté |
Informations sur le produit
Nom :
Mevastatin hydroxy acid sodium salt
Synonymes :
- (b-R,?R,1S,2S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-b,?-dihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid sodium salt[1S-[1a(b-S*,?S*),2a,8b(R*),8a-a]]-1,2,6,7,8,8a-Hexahydro-b,?-dihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naph
Description :
Mevastatin is a cholesterol-lowering drug that belongs to the class of hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. It is used in the treatment of hypercholesterolemia, which is an excess of cholesterol in the blood. Mevastatin inhibits the biosynthesis of cholesterol by competitively inhibiting HMG-CoA reductase, which is an enzyme involved in the production of mevalonic acid from acetyl-CoA and acetoacetyl-CoA. This drug also inhibits the synthesis of pravastatin through a cytochrome P450 enzyme system. Mevastatin has been shown to inhibit transcriptional regulation in human skin fibroblasts and to downregulate mRNA levels for gene products involved in cellular proliferation.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
430.51 g/mol
Formule :
C23H35NaO6
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
